VIM and lung cancer: Vimentin, a key marker of EMT, is closely associated with the malignant phenotype of lung cancer.[40, 41] Kaplan–Meier plot analysis revealed that high vimentin expression was associated with shortened survival time in patients with LUAD (Figure S7A,B, Supporting Information) and that there were higher levels of vimentin‐K104Ac in the serum of patients with early‐stage LUAD than those in healthy individuals (Figure S7C, Supporting Information).